Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128765) titled 'RAI-treated Graves' Disease Cohort' on July 25.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: The First Affiliated Hospital of Xiamen University
Condition:
Graves Disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-25
Target Sample Size: unremitted hyperthyroidism group, normal thyroid function (euthyroid) group, and hypothyroidism group.:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334600
Published by HT Digital Content Services with permission from Health Daily Digest....